Alison Robbins, NP
Nurse Practitioner · Macon, GANPI 1164862710
Payments from drug & device makers
Across 269 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Sanofi$694
- Boehringer Ingelheim$516
- Insmed, Inc.$376
- Grifols USA, LLC$284
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,82597%
- Education$2013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $1,187 |
| GSK | 56 | $1,141 |
| Sanofi | 20 | $694 |
| Boehringer Ingelheim | 26 | $516 |
| Insmed, Inc. | 13 | $376 |
| Grifols USA, LLC | 15 | $284 |
| Mylan Specialty L.p. | 14 | $273 |
| Actelion Pharmaceuticals US, Inc. | 11 | $179 |
| Merck | 8 | $167 |
| Amgen | 11 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $142 |
| Bayer | 6 | $133 |
| United Therapeutics Corporation | 6 | $114 |
| Viatris Specialty LLC | 6 | $111 |
| Baxter Healthcare | 5 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Verona Pharma, Inc. | 3 | $82 |
| Harmony Biosciences LLC | 1 | $49 |
| Johnson & Johnson | 4 | $45 |
| ANI Pharmaceuticals, Inc. | 2 | $34 |
| Resmed Corp | 2 | $32 |
| Electromed, Inc. | 2 | $26 |
| Novartis | 1 | $19 |
| Medtronic | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,026 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 325 | $258,531 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 15 | $133,436 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 149 | $102,211 |
| Fasenra PenBenralizumab | 14 | $81,563 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 116 | $63,526 |
| Breo ElliptaFluticasone/Vilanterol | 108 | $51,559 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 51 | $39,388 |
| SymbicortBudesonide/Formoterol Fumarate | 139 | $39,223 |
| Ambrisentan | 13 | $37,050 |
| Spiriva RespimatTiotropium Bromide | 72 | $36,953 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 739 | $19,855 |
| EliquisApixaban | 28 | $16,274 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 89 | $11,937 |
| Advair HfaFluticasone Propion/Salmeterol | 28 | $10,665 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $1,141 | $377,980564 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,187 | $141,434288 claims |
| Grifols USA, LLCProlastin C | $284 | $133,43615 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $516 | $76,341123 claims |
| PfizerEliquis | $16 | $16,27428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Macon
- Jennifer StanfieldMacon$15K
- Amber WilsonMacon$12K
- Staci BennettMacon$12K
- Ashley VinsonMacon$11K
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.